title: Application of adoptive T-cell therapy using tumor antigen-specific T-cell receptor gene transfer for the treatment of human leukemia.
abstract: The last decade has seen great strides in the field of cancer immunotherapy, especially the treatment of melanoma. Beginning with the identification of cancer antigens, followed by the clinical application of anti-cancer peptide vaccination, it has now been proven that adoptive T-cell therapy (ACT) using cancer antigen-specific T cells is the most effective option. Despite the apparent clinical efficacy of ACT, the timely preparation of a sufficient number of cancer antigen-specific T cells for each patient has been recognized as its biggest limitation. Currently, therefore, attention is being focused on ACT with engineered T cells produced using cancer antigen-specific T-cell receptor (TCR) gene transfer. With regard to human leukemia, ACT using engineered T cells bearing the leukemia antigen-specific TCR gene still remains in its infancy. However, several reports have provided preclinical data on TCR gene transfer using Wilms' tumor gene product 1 (WT1), and also preclinical and clinical data on TCR gene transfer involving minor histocompatibility antigen, both of which have been suggested to provide additional clinical benefit. In this review, we examine the current status of anti-leukemia ACT with engineered T cells carrying the leukemia antigen-specific TCR gene, and discuss the existing barriers to progress in this area.
authors.affiliation: Department of Bioregulatory Medicine, Ehime University Graduate School of Medicine, Shitsukawa, Toon, Ehime 791-0295, Japan.
authors.forename: Toshiki
authors.initials: T
authors.lastname: Ochi
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Fujiwara
authors.forename: Masaki
authors.initials: M
authors.lastname: Yasukawa
mesh_terms: D000951:Antigens, Neoplasm / Q000276:immunology*; D018014:Gene Transfer Techniques; D015316:Genetic Therapy; D006801:Humans; D016219:Immunotherapy, Adoptive / Q000379:methods*; D007938:Leukemia / Q000235:genetics / Q000276:immunology* / Q000628:therapy*; D011948:Receptors, Antigen, T-Cell / Q000235:genetics / Q000627:therapeutic use*; D013601:T-Lymphocytes / Q000276:immunology*
chemical_list: D000951:Antigens, Neoplasm; D011948:Receptors, Antigen, T-Cell
references.citation: Haematologica. 2007 Jan;92(1):72-80
references.pmid: 17229638
references.citation: Blood. 2009 Jan 1;113(1):66-74
references.pmid: 18820130
references.citation: N Engl J Med. 1979 May 10;300(19):1068-73
references.pmid: 34792
references.citation: Expert Opin Ther Targets. 2009 Dec;13(12):1399-410
references.pmid: 19821797
references.citation: Blood. 2009 Jul 16;114(3):535-46
references.pmid: 19451549
references.citation: Blood. 1999 Aug 15;94(4):1201-8
references.pmid: 10438707
references.citation: Curr Opin Immunol. 2009 Apr;21(2):233-40
references.pmid: 19304471
references.citation: Clin Immunol. 2006 May;119(2):135-45
references.pmid: 16458072
references.citation: Cancer Res. 2006 Mar 15;66(6):3331-7
references.pmid: 16540688
references.citation: Blood. 2005 Jul 15;106(2):470-6
references.pmid: 15790789
references.citation: Haematologica. 2010 Jan;95(1):126-34
references.pmid: 19679884
references.citation: Proc Natl Acad Sci U S A. 2006 Jan 31;103(5):1457-62
references.pmid: 16432223
references.citation: Nature. 1986 Mar 20-26;320(6059):232-8
references.pmid: 2421164
references.citation: Proc Natl Acad Sci U S A. 2004 Sep 21;101(38):13885-90
references.pmid: 15365188
references.citation: J Immunol. 2007 Oct 15;179(8):4959-68
references.pmid: 17911580
references.citation: N Engl J Med. 2009 Jan 29;360(5):447-58
references.pmid: 19179314
references.citation: Science. 2002 Oct 25;298(5594):850-4
references.pmid: 12242449
references.citation: Science. 1997 Jun 13;276(5319):1719-24
references.pmid: 9180086
references.citation: J Clin Invest. 2007 Sep;117(9):2562-9
references.pmid: 17710227
references.citation: Blood. 2009 Jun 25;113(26):6541-8
references.pmid: 19389880
references.citation: Nat Med. 2004 Sep;10(9):909-15
references.pmid: 15340416
references.citation: Annu Rev Immunol. 2005;23:101-25
references.pmid: 15771567
references.citation: Nat Med. 2008 Nov;14(11):1264-70
references.pmid: 18978797
references.citation: Blood. 2001 May 1;97(9):2903-7
references.pmid: 11313288
references.citation: Gene Ther. 2000 Aug;7(16):1369-77
references.pmid: 10981663
references.citation: Am J Hematol. 2009 May;84(5):314-5
references.pmid: 19338044
references.citation: Cancer Res. 2007 Apr 15;67(8):3898-903
references.pmid: 17440104
references.citation: Cancer Res. 2007 Mar 15;67(6):2425-9
references.pmid: 17363559
references.citation: J Immunol. 2005 Apr 1;174(7):4415-23
references.pmid: 15778407
references.citation: Nature. 2005 Jun 30;435(7046):1267-70
references.pmid: 15988530
references.citation: Blood. 2007 Jun 1;109(11):4698-707
references.pmid: 17327416
references.citation: Mol Ther. 2009 Apr;17(4):742-9
references.pmid: 19209146
references.citation: Blood. 2005 Nov 1;106(9):3062-7
references.pmid: 16020516
references.citation: J Immunol. 2003 Sep 15;171(6):3287-95
references.pmid: 12960359
references.citation: Clin Cancer Res. 2006 Feb 15;12(4):1229-36
references.pmid: 16489078
references.citation: Science. 2009 Nov 6;326(5954):818-23
references.pmid: 19892975
references.citation: Cancer Res. 2009 Dec 1;69(23):9003-11
references.pmid: 19903853
references.citation: Blood. 2009 Oct 1;114(14):2888-99
references.pmid: 19589923
references.citation: Cancer Res. 2006 Sep 1;66(17):8878-86
references.pmid: 16951205
references.citation: Blood. 2007 Mar 15;109(6):2331-8
references.pmid: 17082316
references.citation: Blood. 2008 Dec 1;112(12):4371-83
references.pmid: 19029455
references.citation: Blood. 2007 Jan 1;109(1):235-43
references.pmid: 16968899
references.citation: Proc Natl Acad Sci U S A. 2002 Dec 10;99(25):16168-73
references.pmid: 12427970
references.citation: J Clin Invest. 2008 Jan;118(1):294-305
references.pmid: 18060041
references.citation: Tissue Antigens. 1995 Apr;45(4):223-31
references.pmid: 7638857
references.citation: Haematologica. 2005 Oct;90(10):1415-21
references.pmid: 16219579
references.citation: Blood. 2003 Oct 15;102(8):2892-900
references.pmid: 12829610
references.citation: Blood. 2003 Nov 15;102(10):3530-40
references.pmid: 12869497
references.citation: Tissue Antigens. 1996 Feb;47(2):93-101
references.pmid: 8851721
references.citation: J Immunol. 2008 Oct 1;181(7):5128-36
references.pmid: 18802117
references.citation: J Exp Med. 2004 Apr 5;199(7):885-94
references.pmid: 15051765
references.citation: Science. 2006 Oct 6;314(5796):126-9
references.pmid: 16946036
references.citation: Nat Med. 2000 Sep;6(9):1018-23
references.pmid: 10973322
references.citation: Proc Natl Acad Sci U S A. 2009 Oct 13;106(41):17469-74
references.pmid: 19805141
references.citation: Gene Ther. 2009 May;16(5):620-8
references.pmid: 19242528
references.citation: N Engl J Med. 1981 Jun 18;304(25):1529-33
references.pmid: 7015133
references.citation: Gene Ther. 2008 May;15(9):695-9
references.pmid: 18288212
references.citation: Blood. 2000 Jan 1;95(1):286-93
references.pmid: 10607714
references.citation: Lancet Oncol. 2009 May;10(5):489-500
references.pmid: 19345145
references.citation: J Immunol. 1999 Jul 1;163(1):507-13
references.pmid: 10384155
references.citation: J Immunother. 2008 Jan;31(1):1-6
references.pmid: 18157006
references.citation: J Immunol. 2008 Jun 1;180(11):7736-46
references.pmid: 18490778
references.citation: J Immunol. 2007 Nov 1;179(9):5803-10
references.pmid: 17947653
references.citation: N Engl J Med. 2008 Jun 19;358(25):2698-703
references.pmid: 18565862